Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

57.71
+10.9223.34%
Post-market: 57.31-0.4050-0.70%19:59 EST
Volume:7.07M
Turnover:395.13M
Market Cap:7.84B
PE:-4.73K
High:59.15
Open:47.39
Low:45.09
Close:46.79
52wk High:59.15
52wk Low:9.57
Shares:135.81M
Float Shares:118.91M
Volume Ratio:2.06
T/O Rate:5.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0122
EPS(LYR):-0.0122
ROE:8.67%
ROA:4.87%
PB:16.82
PE(LYR):-4,733.04

Loading ...

Arrowhead Pharmaceuticals at Risk: Potential Generic Competition Threatens REDEMPLO’s Market Exclusivity

TIPRANKS
·
7 hours ago

Arrowhead Pharmaceuticals’ Earnings Call Highlights FDA Approval and Strong Financials

TIPRANKS
·
12 hours ago

BUZZ-Nasdaq biotech index on track for record closing high

Reuters
·
17 hours ago

Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On Wednesday

Benzinga_recent_news
·
20 hours ago

Arrowhead rises 9.0%

TIPRANKS
·
Yesterday

Arrowhead Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Yesterday

Stock Track | Arrowhead Pharmaceuticals Soars 5.49% on Analyst Upgrades and Strategic Developments

Stock Track
·
Yesterday

Stock Track | Arrowhead Pharmaceuticals Soars 5.49% Intraday on Morgan Stanley Price Target Hike and Bullish Analyst Sentiment

Stock Track
·
Yesterday

Arrowhead price target raised to $48 from $45 at Morgan Stanley

TIPRANKS
·
Yesterday

Arrowhead Pharmaceuticals: Promising Growth with Redemplo Launch and Strategic Developments in Obesity Treatments

TIPRANKS
·
Yesterday

Arrowhead Pharma Q4 EPS $(0.09) Beats $(0.29) Estimate, Sales $256.478M Beat $175.862M Estimate

Benzinga
·
Yesterday

Arrowhead Pharmaceuticals FY25 EPS $(0.01) Up From $(5.00) YoY; Revenue $829.448M Up From $3.551M YoY

Benzinga
·
Yesterday

Press Release: Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results

Dow Jones
·
Yesterday

Arrowhead options imply 11.3% move in share price post-earnings

TIPRANKS
·
Yesterday

Stock Track | Arrowhead Pharmaceuticals Soars 5% on $200 Million Payment from Sarepta and Upcoming Earnings

Stock Track
·
Yesterday

Stock Track | Arrowhead Pharmaceuticals Soars 5.02% on $200 Million Milestone Payment from Sarepta

Stock Track
·
Yesterday

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from B. Riley Securities

TIPRANKS
·
Nov 25

Top News Today/Canada: Barrick Makes a Deal With Mali

Dow Jones
·
Nov 25

Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics

Reuters
·
Nov 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 24